Inventor
PUSCHL ASK
DK15 patents
⚠️ This page may combine multiple inventors who share the name “PUSCHL ASK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUNDBECK & CO AS H
8 patentsUS7144884B2Dec 5, 2006
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H42 citations95
US7138407B2Nov 21, 2006
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H41 citations95
US7148238B2Dec 12, 2006
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H23 citations92
US9090575B2Jul 28, 2015
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H5 citations82
US7732463B2Jun 8, 2010
4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H13 citations81
US9023870B2May 5, 2015
Positive allosteric modulators of nicotinic acetylcholine receptor
LUNDBECK & CO AS H0 citations49
US8927738B2Jan 6, 2015
2-arylimidazole derivatives as PDE10A enzyme inhibitors
LUNDBECK & CO AS H0 citations49
US8785653B2Jul 22, 2014
(3-aryl-1H-1,2,4-triazol-5-yl)-linked heterocycle derivatives
LUNDBECK & CO AS H0 citations49
H LUNDBECK AS
4 patentsUS9549919B2Jan 24, 2017
Positive allosteric modulators of nicotinic acetylcholine receptor
H LUNDBECK AS2 citations70
US9708280B2Jul 18, 2017
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
H LUNDBECK AS1 citations62
US10844029B2Nov 24, 2020
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
H LUNDBECK AS0 citations51
US9889122B2Feb 13, 2018
Positive allosteric modulators of nicotinic acetylcholine receptor
H LUNDBECK AS0 citations49